CORC

浏览/检索结果: 共39条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:  Peng, Jie;  Zou, Dan;  Han, Lijie;  Yin, Zuomin;  Hu, Xiao
收藏  |  浏览/下载:23/0  |  提交时间:2022/02/14
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China. 期刊论文
Value in health regional issues, 2019, 卷号: 18
作者:  Li Xinyan;  Li Weichen;  Hou Lingping
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/05
Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China 期刊论文
Clinical Therapeutics, 2019
作者:  Xiaoyou Li;  Muhammad Abbas;  Yun Li;  Yue Teng;  Ying Fang
收藏  |  浏览/下载:16/0  |  提交时间:2019/12/17
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12
作者:  Yang, Jin-ji;  Zhou, Jianying;  Wang, Jie;  An, Tongtong;  Yang, Lei
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506) 期刊论文
LUNG CANCER, 2018, 卷号: 123
作者:  Song, Yong;  Zhou, Qing;  Zhang, Xin;  Chen, Gong-Yan;  Zhong, Dian-Sheng
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12
作者:  Lu, Shun;  Chang, Jianhua;  Liu, Xiaoqing;  Shi, Jianhua;  Lu, You
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous NonSmall Cell Lung Cancer (CTONG1506) 会议论文
作者:  Yu, P.;  Zhou, Q.;  Song, Y.;  Zhang, X.;  Chen, G.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: Vol.36 No.12, 页码: 1207
作者:  Lu, S;  Chang, JH;  Liu, XQ;  Shi, JH;  Lu, Y
收藏  |  浏览/下载:11/0  |  提交时间:2019/02/25
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China 期刊论文
Value in health regional issues, 2018, 卷号: 18, 页码: 1-7
作者:  Li Xinyan[1];  Li Weichen[2];  Hou Lingping[3]
收藏  |  浏览/下载:3/0  |  提交时间:2019/04/22


©版权所有 ©2017 CSpace - Powered by CSpace